INVO Fertility (IVF) Operating Expenses (2011 - 2025)

INVO Fertility has disclosed Operating Expenses across 15 years of filings, most recently posting $3.4 million for Q3 2025.

• Quarterly Operating Expenses rose 24.11% year-over-year to $3.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $32.1 million (up 159.25% YoY) and the FY2024 annual result came in at $14.7 million, up 49.75% from the prior year.
• Operating Expenses retreated to $3.4 million in Q3 2025, from $4.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $18.7 million in Q1 2025 and bottomed at $1.9 million in Q3 2023.
• The 5-year median for Operating Expenses is $2.8 million (2022), against an average of $3.8 million.
• Year-over-year, Operating Expenses plunged 32.58% in 2023 and surged 507.74% in 2025.
• INVO Fertility's Operating Expenses stood at $2.5 million in 2021, then advanced by 19.98% to $3.0 million in 2022, then decreased by 3.54% to $2.9 million in 2023, then soared by 78.19% to $5.2 million in 2024, then tumbled by 34.13% to $3.4 million in 2025.
• According to Business Quant data, Operating Expenses over the past three periods registered $3.4 million, $4.9 million, and $18.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.